Judith Thijs
12PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Oct 25, 2024
Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients.Coco Dekkers, Hidde Smits, Dora Stölzl
|Feb 09, 2024
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy.Roselie Achten, Judith Thijs, Marlot van der Wal
|Mar 19, 2023
Dupilumab-associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis.Roselie Achten, Judith Thijs, Marlot van der Wal
|Dec 23, 2022
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients.Roselie Achten, Judith Thijs, Chantal van Luijk
|Jul 15, 2022
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis.Lotte S Spekhorst, Daphne Bakker, Julia Drylewicz
|Mar 16, 2022
Ocular surface disease is common in moderate-to-severe atopic dermatitis patients.Roselie E Achten, Daphne S Bakker, Chantal M van Luijk
Pageof 2
Frequent Collaborators
12 joint publications
Marjolein S de Bruin-Weller
8 joint publications
Daphne S Bakker
5 joint publications
Julia Drylewicz
4 joint publications
Edward Knol
4 joint publications
Lieneke F M Ariëns
4 joint publications
Roselie E Achten
3 joint publications
DirkJan Hijnen
3 joint publications
Lotte Spekhorst
2 joint publications
Stefan Nierkens
2 joint publications
Marlot van der Wal
